Pages that link to "Q39463322"
Jump to navigation
Jump to search
The following pages link to Calcium signaling and neurodegenerative diseases (Q39463322):
Displaying 50 items.
- Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials (Q24235371) (← links)
- Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis (Q24308696) (← links)
- Clarifying lysosomal storage diseases (Q24620532) (← links)
- Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model (Q24624879) (← links)
- Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease (Q26747203) (← links)
- Calmodulin regulation (calmodulation) of voltage-gated calcium channels (Q26827282) (← links)
- Iron dysregulation in Huntington's disease (Q26829932) (← links)
- The synaptic maintenance problem: membrane recycling, Ca2+ homeostasis and late onset degeneration (Q27000356) (← links)
- Secondary Structure of Huntingtin Amino-Terminal Region (Q27657408) (← links)
- Beta conformation of polyglutamine track revealed by a crystal structure of Huntingtin N-terminal region with insertion of three histidine residues (Q27676093) (← links)
- Blockage of spontaneous Ca2+ oscillation causes cell death in intraerythrocitic Plasmodium falciparum (Q28481076) (← links)
- Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2 (Q28513553) (← links)
- Development and implementation of a high-throughput compound screening assay for targeting disrupted ER calcium homeostasis in Alzheimer's disease (Q28535175) (← links)
- A Novel 1,4-Dihydropyridine Derivative Improves Spatial Learning and Memory and Modifies Brain Protein Expression in Wild Type and Transgenic APPSweDI Mice (Q28547847) (← links)
- Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease (Q28594357) (← links)
- SorCS2-mediated NR2A trafficking regulates motor deficits in Huntington's disease (Q29994841) (← links)
- Therapeutic prospects for spinocerebellar ataxia type 2 and 3. (Q30410969) (← links)
- Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease (Q30491641) (← links)
- Mitochondrial dysfunction and calcium deregulation by the RanBP9-cofilin pathway (Q30557488) (← links)
- Lipid rafts serve as signaling platforms for mGlu1 receptor-mediated calcium signaling in association with caveolin (Q30572941) (← links)
- The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease (Q30594530) (← links)
- Loss of function of the ALS protein SigR1 leads to ER pathology associated with defective autophagy and lipid raft disturbances (Q30669509) (← links)
- Long-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic mice (Q30887483) (← links)
- Aberrant Ca2+ handling in lysosomal storage disorders (Q33727058) (← links)
- Anesthetic-induced neurodegeneration mediated via inositol 1,4,5-trisphosphate receptors (Q33755235) (← links)
- TRPC channels and their implication in neurological diseases (Q33757601) (← links)
- Region-specific protein abundance changes in the brain of MPTP-induced Parkinson's disease mouse model (Q33810589) (← links)
- Tetrabenazine is neuroprotective in Huntington's disease mice (Q33863426) (← links)
- Activation of mGluR5 attenuates NMDA-induced neurotoxicity through disruption of the NMDAR-PSD-95 complex and preservation of mitochondrial function in differentiated PC12 cells (Q33907912) (← links)
- Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction (Q34203241) (← links)
- Aberrant calcium signaling by transglutaminase-mediated posttranslational modification of inositol 1,4,5-trisphosphate receptors (Q34281322) (← links)
- Computational analysis of calcium signaling and membrane electrophysiology in cerebellar Purkinje neurons associated with ataxia (Q34306449) (← links)
- Continuously tunable Ca(2+) regulation of RNA-edited CaV1.3 channels (Q34377391) (← links)
- Pathogenic polyglutamine expansion length correlates with polarity of the flanking sequences (Q34544146) (← links)
- TDP-43 toxicity proceeds via calcium dysregulation and necrosis in aging Caenorhabditis elegans motor neurons (Q34674858) (← links)
- General anesthetic isoflurane modulates inositol 1,4,5-trisphosphate receptor calcium channel opening. (Q34799569) (← links)
- A mitocentric view of Alzheimer's disease suggests multi-faceted treatments (Q34902708) (← links)
- Role of Inositol 1,4,5-Trishosphate Receptors in Pathogenesis of Huntington’s Disease and Spinocerebellar Ataxias (Q34981549) (← links)
- The involvement of PI3K-mediated and L-VGCC-gated transient Ca2+ influx in 17β-estradiol-mediated protection of retinal cells from H2O2-induced apoptosis with Ca2+ overload. (Q35040631) (← links)
- Bilayer measurement of endoplasmic reticulum Ca2+ channels (Q35049794) (← links)
- Measurement of total calcium in neurons by electron probe X-ray microanalysis (Q35058092) (← links)
- Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment (Q35072356) (← links)
- A dopamine receptor contributes to paraquat-induced neurotoxicity in Drosophila. (Q35078638) (← links)
- Expanded polyglutamine-binding peptoid as a novel therapeutic agent for treatment of Huntington's disease (Q35244160) (← links)
- Evaluating the SERCA2 and VEGF mRNAs as Potential Molecular Biomarkers of the Onset and Progression in Huntington's Disease (Q35542530) (← links)
- The Interface between Cytoskeletal Aberrations and Mitochondrial Dysfunction in Alzheimer's Disease and Related Disorders (Q35542857) (← links)
- Dantrolene is neuroprotective in Huntington's disease transgenic mouse model (Q35605391) (← links)
- Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias (Q35670193) (← links)
- Proteome-wide characterization of signalling interactions in the hippocampal CA4/DG subfield of patients with Alzheimer's disease (Q35713134) (← links)
- Analyzing and Modeling the Kinetics of Amyloid Beta Pores Associated with Alzheimer's Disease Pathology (Q35766862) (← links)